Analyst firms · H.C. Wainwright · TGTX

H.C. Wainwright TGTX price target and rating history

TG Therapeutics Inc. (TGTX) · Health Care

H.C. Wainwright rates TG Therapeutics Inc. (TGTX) Buy with a $60 price target, as of its latest action on Oct 6, 2025. It has published 5 rating actions on TGTX since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$60
Median target, all firms
Too few
Actions on TGTX
5

H.C. Wainwright price target on TGTX

$84$72$6020222023202420252026
H.C. Wainwright price target on TGTX, each point a stated target, August 2021 to October 2025.

Every H.C. Wainwright rating on TGTX

Questions about H.C. Wainwright and TGTX

What is H.C. Wainwright's price target for TGTX?
H.C. Wainwright's latest stated price target for TG Therapeutics Inc. (TGTX) is $60, from its action on Oct 6, 2025.
What is H.C. Wainwright's rating on TGTX?
H.C. Wainwright rates TGTX Buy, a bullish rating, as of Oct 6, 2025.
When did H.C. Wainwright last change its view on TGTX?
On Oct 6, 2025, H.C. Wainwright resumes coverage at Buy, price target $60.

More TGTX rating histories

All H.C. Wainwright ratingsTGTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.